Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has shared an announcement.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced an H shareholders’ class meeting scheduled for July 21, 2025, to consider a special resolution regarding a merger agreement with Sunshine Lake Pharma Co., Ltd. The approval of this merger is contingent on a 75% affirmative vote from independent H shareholders, with less than 10% opposition. This meeting is crucial for the company’s strategic direction and could significantly impact its market position and stakeholder interests.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China, focusing on the development, production, and sale of pharmaceutical products.
Average Trading Volume: 9,690,048
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.11B
For an in-depth examination of 1558 stock, go to TipRanks’ Overview page.